These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33585326)

  • 1. Inhaled Tranexamic Acid for Non-Massive Haemoptysis in a Rivaroxaban-Receiving Patient Not Responding to the Oral Form.
    Eltahir M; Elshafei MN; Elzouki A
    Eur J Case Rep Intern Med; 2020; 7(12):001930. PubMed ID: 33585326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BET 1: Does inhaled tranexamic acid reduce morbidity in adults with haemoptysis?
    Mervau J; Jason S; Jones JS
    Emerg Med J; 2020 Jan; 37(1):45-46. PubMed ID: 31848266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of tranexamic acid in haemoptysis: A randomized, controlled pilot study.
    Bellam BL; Dhibar DP; Suri V; Sharma N; Varma SC; Malhotra S; Bhalla A
    Pulm Pharmacol Ther; 2016 Oct; 40():80-3. PubMed ID: 27470681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Massive haemoptysis from right middle lobe bronchus managed by customized silicon stents.
    Xu W; Wang H; He H; Hu H; Lu H; Li G
    Respirol Case Rep; 2019 Jul; 7(5):e00418. PubMed ID: 30956792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of haemoptysis in a girl with Noonan syndrome.
    Mopeli RK; Lebea M; Verwey C
    Afr J Thorac Crit Care Med; 2020; 26(3):. PubMed ID: 34240029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergency surgery for massive haemoptysis.
    Metin M; Sayar A; Turna A; Solak O; Erkan L; Dinçer SI; Bedirhan MA; Gürses A
    Acta Chir Belg; 2005; 105(6):639-43. PubMed ID: 16438076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchial artery embolization to control haemoptysis.
    Wong KP; Young N; Marksen G
    Australas Radiol; 1994 Nov; 38(4):256-9. PubMed ID: 7993246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does tranexamic acid stop haemoptysis?
    Moen CA; Burrell A; Dunning J
    Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):991-4. PubMed ID: 23966576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifibrinolytic therapy to reduce haemoptysis from any cause.
    Prutsky G; Domecq JP; Salazar CA; Accinelli R
    Cochrane Database Syst Rev; 2012 Apr; (4):CD008711. PubMed ID: 22513965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between inhaler use and risk of haemoptysis in patients with non-cystic fibrosis bronchiectasis.
    Jang EJ; Lee CH; Yoon HI; Kim YJ; Kim JM; Choi SM; Yim JJ; Kim DK
    Respirology; 2015 Nov; 20(8):1213-21. PubMed ID: 26293490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of an unusual cause of life-threatening haemoptysis: a multidisciplinary approach.
    Pramanik K; Webb P; Hamid R
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34016628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cause, treatment and outcome of patients with life-threatening haemoptysis.
    Stebbings AE; Lim TK
    Singapore Med J; 1999 Feb; 40(2):67-9. PubMed ID: 10414159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rivaroxaban reversal with prothrombin complex concentrate or tranexamic acid in healthy volunteers.
    Levy JH; Moore KT; Neal MD; Schneider D; Marcsisin VS; Ariyawansa J; Weitz JI
    J Thromb Haemost; 2018 Jan; 16(1):54-64. PubMed ID: 29106076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Massive Haemoptysis Treated with Bronchial Artery Embolisation in COVID-19 Infection.
    Mejri I; Boubaker N; Znegui T; Daboussi S; Aichaouia C; Mhamdi S; Moatemri Z
    Eur J Case Rep Intern Med; 2022; 9(8):003475. PubMed ID: 36093306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty.
    Clavé A; Gérard R; Lacroix J; Baynat C; Danguy des Déserts M; Gatineau F; Mottier D
    Bone Joint J; 2019 Feb; 101-B(2):207-212. PubMed ID: 30700116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of ankaferd blood stopper used for massive haemoptysis in a patient with mounier-kuhn syndrome: A case report.
    Yazici O; Gulen ST; Ceylan E
    J Pak Med Assoc; 2020 Apr; 70(4):731-733. PubMed ID: 32296224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embolisation of a bronchial artery of anomalous origin in massive haemoptysis.
    Md Ralib AR; Han NT; Hin HS; Muda AS
    Malays J Med Sci; 2010 Jul; 17(3):55-60. PubMed ID: 22135550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endovascular therapy in the management of moderate and massive haemoptysis.
    Poyanli A; Acunas B; Rozanes I; Guven K; Yilmaz S; Salmaslioglu A; Terzibasioglu E; Cirpin R
    Br J Radiol; 2007 May; 80(953):331-6. PubMed ID: 17392400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of patients presenting with haemoptysis to a Tertiary Care Italian Emergency Department: the Florence Haemoptysis Score (FLHASc).
    Vanni S; Bianchi S; Bigiarini S; Casula C; Brogi M; Orsi S; Acquafresca M; Corbetta L; Grifoni S
    Intern Emerg Med; 2018 Apr; 13(3):397-404. PubMed ID: 28160237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dilemma on the treatment of haemoptysis: an analysis of 249 patients.
    Tunçözgür B; Işik AF; Nacak I; Akar E; Elbeyli L
    Acta Chir Belg; 2007 Jun; 107(3):302-6. PubMed ID: 17685258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.